999 resultados para Optical modes


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Purpose: To determine whether the need for retreatment after an initial phase of 3 monthly intravitreal injections of ranibizumab shows an intra-individual regular rhythm and to what degree it varies between different patients. Methods: Prospective study with 42 patients with exudative AMD, treatment naïve. Loading dose of 3 monthly doses of ranibizumab (0,5 mg), followed by a 12 months pro re nata (PRN) regimen according to early exudative signs on HD-OCT Cirrus, Zeiss. The follow-up visits were intensified (week 4, 5, 6, 7, 8, 10, 12, 14, 16, 20, etc after each injection) in order to detect recurrences early, and injection followed within 3 days in cases of subretinal fluid, cysts, or central thickness increase of>50microns. Intervals were calculated between injections for the 12 month follow-up with PRN treatment. Variability was expressed as standard deviation (SD). Results: Visual acuity (VA) improved from a mean ETDRS score of 61.6 (SD 10.8) at baseline to 68.0 (SD 10.2) at month 3 and to 74.7(SD 9.0) at month 12. The 15 patients who have already completed the study showed maintenance of the VA improvement. Central foveal thickness improved from a mean value of 366 microns (baseline) to 253 microns (month 3), well maintained thereafter. Mean number of injections was 8.8 (SD 3.5,range 0-12) per 12 months of follow-up (after 3 doses), with mean individual treatment-recurrence (TR) intervals ranging from 28->365 days (mean 58). Intraindividual variability of TR intervals (SD) was 7.1 days as a mean value (range 1.7¡V22.6). It ranged within 20% of the mean intra-individual interval for 30 (91%) and within 15% for 21 patients (64%). The first interval was within 1 week of the mean intra-individual interval in 64% and within 2 weeks in 89% of patients. Conclusions: The majority of AMD patients showed a relatively stable rhythm for PRN injections of ranibizumab after initial loading phase, associated with excellent functional/anatomical results. The initial interval last loading dose-first recurrence may have a predictive value for further need of treatment, potentially facilitating follow-up and patient care.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Textes d'Aurélien Boutaud, Jean-Claude Galey, Sylvia Generoso, Susana Jourdan, Jacques Mirenowicz, René Nouailhat, Sylvain Piron, Cécile Renouard, Yvan Rytz et Marie-Christine Zélem.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Pearson correlation coefficients were applied for the objective comparison of 30 black gel pen inks analysed by laser desorption ionization mass spectrometry (LDI-MS). The mass spectra were obtained for ink lines directly on paper using positive and negative ion modes at several laser intensities. This methodology has the advantage of taking into account the reproducibility of the results as well as the variability between spectra of different pens. A differentiation threshold could thus be selected in order to avoid the risk of false differentiation. Combining results from positive and negative mode yielded a discriminating power up to 85%, which was better than the one obtained previously with other optical comparison methodologies. The technique also allowed discriminating between pens from the same brand.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1819/02/15 (N9,A23).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1822/07/25 (N41,A26).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1819/02/10 (N8,A23).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1819/07/20 (N40,A23).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1821/08/20 (N46,A25).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1820/05/15 (N27,A24).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1822/02/15 (N9,A26).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1820/10/20 (N58,A24).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1822/07/20 (N40,A26).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1819/05/10 (N26,A23).

Relevância:

20.00% 20.00%

Publicador:

Resumo:

1819/11/15 (N63,A23).